Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Inhibitory Control: Effects of Modulation

NCT: NCT04247334 · COMPLETED

NCT IDNCT04247334
StatusCOMPLETED
Start Date2019-11-14
Completion2024-02-25
SponsorButler Hospital (OTHER)
First posted
Last updated

Brief Summary

Inhibitory control is relevant to many clinical disorders, including substance abuse/dependence, obsessive-compulsive disorder, and attention-deficit hyperactivity disorder. This proposal is designed to assess brain networks related to response inhibition in healthy young adults, and use neuromodulation to change these networks and behavioral performance on a response inhibition task. Having an understanding of the brain mechanisms involved in response inhibition may enable us to improve pre-existing treatments for disorders with inhibitory control difficulties.

Frequently Asked Questions

What is Inhibitory Control: Effects of Modulation?

Inhibitory Control: Effects of Modulation is a clinical trial registered under NCT04247334. Current status: COMPLETED.

What is the status of NCT04247334?

The current status of NCT04247334 (Inhibitory Control: Effects of Modulation) is: COMPLETED.

When did Inhibitory Control: Effects of Modulation start?

Inhibitory Control: Effects of Modulation started on 2019-11-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.